BeStock  
Stocks › Biotechnology › RLAY

Relay Therapeutics RLAY

US equityMarket cap rank #2302Biotechnology
$16.12 +$0.21 (+1.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $16.19 +0.46%
Open$15.59
Prev close$15.91
Day range$15.17 – $16.33
Volume3.98M
Market cap$3.56B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$90.25M-12.3% YoY
Net profit-$81.75M-10.2% YoY
Diluted EPS-$0.37+14.0% YoY
Free cash flow-$63.93M-2.9% YoY
Operating cash flow-$63.93M

Revenue, last 8 quarters

$0.0Dec '24$7.7MMar '25$677.0KJun '25$0.0Sep '25$7.0MDec '25$3.0MMar '26$350.0KJun '26$0.0Sep '26

Net profit, last 8 quarters

$-76.0MDec '24$-77.1MMar '25$-70.4MJun '25$-74.1MSep '25$-54.9MDec '25$-73.3MMar '26$-83.7MJun '26$-81.7MSep '26

Diluted EPS by quarter

-0.45Dec '24-0.46Mar '25-0.41Jun '25-0.43Sep '25-0.32Dec '25-0.41Mar '26-0.41Jun '26-0.37Sep '26

Free cash flow by quarter

$-57.9MDec '24$-73.6MMar '25$-55.3MJun '25$-62.1MSep '25$-44.9MDec '25$-51.1MMar '26$-54.1MJun '26$-63.9MSep '26

Annual revenue

$82.7MFY20$3.0MFY21$1.4MFY22$25.5MFY23$10.0MFY24$15.4MFY25

Profitability & balance sheet

Operating margin-3,094.6%
Net margin-2,837.0%
Return on equity-41.2%
Return on assets-37.4%
Return on invested capital-43.1%
Current ratio14.62
Liabilities / assets9.2%
Cash & investments$848.64M
Total debt$23.54M
Net cash (debt)$825.10M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $0.00 $350,000.00 $3.00M $15.36M $7.00M
Total Operating Revenue $0.00 $350,000.00 $3.00M $15.36M $7.00M
Operating Expense $90.25M $91.17M $81.59M $318.09M $67.63M
Selling and Admin Expenses $13.11M $14.69M $11.03M $56.71M $12.22M
-General & Admin Expense $13.11M $14.69M $11.03M $56.71M $12.22M
Research & Development $77.14M $76.48M $70.56M $261.38M $55.42M
Operating Profit -$90.25M -$90.82M -$78.59M -$302.74M -$60.63M
Net Non-Operating Interest Income (Expense) $8.50M $7.12M $5.35M $27.04M $5.71M
Non-Operating Interest Income $8.50M $7.12M $5.35M $27.04M $5.71M
Other Income (Expense) -$2,000.00 $2,000.00 -$53,000.00 -$776,000.00 $30,000.00
Other Non-Operating Income (Expenses) -$2,000.00 $2,000.00 -$53,000.00 -$776,000.00 $30,000.00
Pretax Profit -$81.75M -$83.71M -$73.29M -$276.48M -$54.89M
Net Profit -$81.75M -$83.71M -$73.29M -$276.48M -$54.89M
Profit from Continuing Operations -$81.75M -$83.71M -$73.29M -$276.48M -$54.89M
Net Income to Parent Company -$81.75M -$83.71M -$73.29M -$276.48M -$54.89M
Net Income to Common Stockholders -$81.75M -$83.71M -$73.29M -$276.48M -$54.89M
Basic EPS -$0.37 -$0.41 -$0.41 -$1.61 -$0.32
Diluted EPS -$0.37 -$0.41 -$0.41 -$1.61 -$0.32
Special Income (Charges) – – – $0.00 $0.00
-Less:Restructuring and Mergern & Acquisition – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $901.69M $967.46M $699.61M $621.33M $621.33M
Total Current Assets $864.85M $928.08M $658.46M $578.28M $578.28M
Cash and Cash Equivalents & Short-Term Investments $848.64M $910.93M $642.07M $554.52M $554.52M
-Cash and Cash Equivalents $124.18M $121.19M $204.59M $84.02M $84.02M
-Short Term Investments $724.46M $789.75M $437.48M $470.50M $470.50M
Prepaid Assets $8.68M $8.74M $11.84M $17.79M $17.79M
Other Current Assets $7.53M $8.41M $4.56M $5.97M $5.97M
Total Non-Current Assets $36.84M $39.38M $41.15M $43.05M $43.05M
Net PPE $30.90M $38.04M $39.82M $41.72M $41.72M
-Gross PPE $30.90M $38.04M $39.82M $63.26M $63.26M
Goodwill and Other Intangible Assets $4.75M – – $0.00 $0.00
Other Non-Current Assets $1.20M $1.34M $1.34M $1.34M $1.34M
Total Liabilities $82.70M $77.45M $57.43M $54.27M $54.27M
Total Current Liabilities $59.15M $50.80M $29.75M $25.58M $25.58M
Payables $9.19M $11.46M $4.10M $7.71M $7.71M
-Accounts Payable $9.19M $11.46M $4.10M $7.71M $7.71M
Current Accrued Expenses $45.06M $34.08M $20.91M $13.65M $13.65M
Short-Term Debt and Capital Lease Obligation $3.49M $4.01M $3.89M $3.77M $3.77M
-Current Capital Lease Obligation $3.49M $4.01M $3.89M $3.77M $3.77M
Other Current Liabilities $1.42M $1.25M $847,000.00 $463,000.00 $463,000.00
Total Non-Current Liabilities $23.54M $26.64M $27.68M $28.69M $28.69M
Long Term Debt and Capital Lease Obligation $23.54M $26.64M $27.68M $28.69M $28.69M
-Long Term Capital Lease Obligation $23.54M $26.64M $27.68M $28.69M $28.69M
Total Equity $819.00M $890.01M $642.18M $567.06M $567.06M
Stockholders' Equity $819.00M $890.01M $642.18M $567.06M $567.06M
Capital Stock $212,000.00 $211,000.00 $182,000.00 $168,000.00 $168,000.00
-Common Stock $212,000.00 $211,000.00 $182,000.00 $168,000.00 $168,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $3.08B $3.06B $2.73B $2.58B $2.58B
Retained Earnings -$2.25B -$2.17B -$2.09B -$2.01B -$2.01B
Gains/Losses Not Affecting Retained Earnings -$5.36M -$1.55M -$172,000.00 $733,000.00 $733,000.00
-Accumulated Depreciation – – – -$21.55M -$21.55M
Current Deferred Liabilities – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$63.93M -$54.11M -$51.11M -$235.46M -$44.87M
Net cash flow from continuing operations -$63.93M -$54.11M -$51.11M -$235.46M -$44.87M
Net Income from Continuing Operations -$81.75M -$83.71M -$73.29M -$276.48M -$54.89M
Depreciation & Depletion & Amortization $280,000.00 $360,000.00 $504,000.00 $3.56M $599,000.00
Change in Working Capital $5.32M $20.68M $11.92M -$23.31M -$2.82M
-Change in Prepaid Assets $940,000.00 -$751,000.00 $7.36M $1.61M $3.82M
-Change in Payables and Accrued Expense $3.95M $20.52M $3.67M -$11.44M -$6.53M
-Change in Other Current Liabilities $172,000.00 $405,000.00 $384,000.00 -$1.53M -$615,000.00
-Change In Other Working Capital $250,000.00 $507,000.00 $506,000.00 -$11.95M $508,000.00
Net cash flow from investing $62.37M -$353.03M $32.90M $192.80M $35.46M
Net Cash Flow from Continuing Investing Activities $62.37M -$353.03M $32.90M $192.80M $35.46M
Net PPE Purchase and Sale $0.00 $0.00 $0.00 -$410,000.00 -$1,000.00
Net Investment Purchase and Sale $62.37M -$353.03M $32.90M $193.21M $35.46M
Financing Cash Flow $4.42M $323.74M $138.78M $1.60M $934,000.00
Net Cash Flow from Continuing Financing Activities $4.42M $323.74M $138.78M $1.60M $934,000.00
Net Common Stock Issuance $0.00 $318.94M $137.09M $0.00 $0.00
Proceeds from Stock Option Exercised $4.42M $4.79M $1.69M $1.60M $934,000.00
Ending Cash Balance $125.38M $122.53M $205.93M $85.35M $85.35M
Net Change in Cash $2.86M -$83.40M $120.57M -$41.05M -$8.47M
Beginning Cash Balance $122.53M $205.93M $85.35M $126.41M $93.82M
Free Cash Flow -$63.93M -$54.11M -$51.11M -$235.87M -$44.87M
Gain/Loss from Continuing Operations – – – $1.00M $35,000.00
-Change in Receivables – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on RLAY.

Sign in to join the discussion.

Scroll to Top